Gossamer Bio Inc reports results for the quarter ended in March - Earnings Summary

Gossamer Bio

09/05/2023 21:27

* Gossamer Bio Inc  GOSS.OQ  reported a quarterly adjusted
loss
of 52 cents​​ per share for the quarter ended in March. The mean
expectation of ten analysts for the quarter was for a loss of 53
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Gossamer Bio Inc's reported EPS for the quarter was a loss
of 52
cents​.
    * The mean earnings estimate of analysts had risen by
about 10.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Gossamer Bio Inc shares had risen by 7.9% this quarter and
lost 37.3% so far this year.
    * The company reported a quarterly loss of $49.17 million.
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 08:27 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.53          -0.52          Beat
 Dec. 31 2022      -0.62          -0.59          Beat
 Sep. 30 2022      -0.64          -0.65          Missed
 Jun. 30 2022      -0.70          -0.74          Missed